RHI Magnesita N.V.
("RHI Magnesita" or the "Company")
Notice of 2018 Full Year Results
RHI Magnesita will announce results for the year ended 31 December 2018 on Wednesday 27 March 2019.
A presentation for analysts and investors will take place at 8.30am GMT on 27 March 2019 at the offices of Peel Hunt LLP, Moor House, 120 London Wall, EC2Y 5ET and will be available to view via webcast. Webcast details will be published at the time of the results.
For further enquiries, please contact:
Guy Marks, Head of Investor Relations
Tel +44 7741 730681
E‐mail: [email protected]
About RHI Magnesita
RHI Magnesita is the global leading supplier of high-grade refractory products, systems and solutions which are indispensable for industrial high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves more than 10,000 customers in nearly all countries around the world. The Company has broad geographic diversification with more than 14,000 employees in 35 main production sites and more than 70 sales offices. RHI Magnesita intends to use its global leadership position in terms of revenue, greater scale, complementary product portfolio and diversified geographic presence around the world to target opportunistically those countries and regions benefitting from more dynamic economic growth prospects.
Its shares have a premium listing on the London Stock Exchange (symbol: RHIM) and are a constituent of the FTSE 250 index. For more information please visit: www.rhimagnesita.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.